Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

Monitoring Over a Decade in the Serotype Prevalence of Streptococcus pneumoniae in Iran: A Systematic Review and Meta-analysis

Author(s): Setareh Mamishi, Babak Pourakbari, Abbas Bahador, Reihaneh Hosseinpour Sadeghi and Maryam Pourhajibagher*

Volume 24, Issue 3, 2024

Published on: 03 November, 2023

Article ID: e031123223116 Pages: 11

DOI: 10.2174/0118715265265907231025111012

Price: $65

Abstract

Background: There is no comprehensive information about the circulating serotypes of Streptococcus pneumoniae in Iran in recent years. This study aimed to summarize information about the changes over a decade in the serotype prevalence of S. pneumoniae in Iran.

Methods: We performed a comprehensive search in PubMed/Medline, Web of Science, Science Direct, and the Iranian Database, such as Magiran and SID, from January 2011 to February 2023. The systematic process, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), was carried out by two researchers who were both independent and calibrated. Statistical analyses were carried out using Comprehensive Meta-Analysis software. Identifying and measuring heterogeneity were done using I2 and the chi-square test. Finally, Begg’s rank correlation test was used in combination with a funnel plot to evaluate any possible publication bias.

Results: The search returned 16 relevant results, with a total of 1575 isolates. Of those studies, eight studies reported the distribution of S. pneumoniae serotypes among patients, three studies among healthy individuals, and five studies among both groups. As the meta-analysis revealed, the most common serotypes were 23F (n = 299, 14.1% [95% CI: 9.7-19.9]; I2 = 84.3%; P<0.001 for heterogeneity), 19F (n = 221, 13.4% [95% CI: 9.9-17.9; I2 = 76.7%; P<0.001 for heterogeneity]), and 19A (n = 102, 8.7% [95% CI: 6.5-11.7; I2 = 54.3%; P<0.001 for heterogeneity]). Moreover, Begg’s test (P = 0.160, 0.173, and 0.176 for 23F, 19F, and 19A, respectively) showed no evidence of publication bias.

Conclusion: Based on our pooled results, the majority of the serotypes of pneumococci in the Iranian population were 23F, 19F, and 19A, respectively, over the last decade. The findings can be valuable in selecting effective pneumococcal vaccine candidates and targeted antibiotics in Iranian patients.

Graphical Abstract

[1]
Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 2012; 25(3): 409-19.
[http://dx.doi.org/10.1128/CMR.00018-12] [PMID: 22763632]
[2]
Alizadeh Chamkhaleh M, Esteghamati A, Sayyahfar S, et al. Serotype distribution of Streptococcus pneumoniae among healthy carriers and clinical patients: A systematic review from Iran. Eur J Clin Microbiol Infect Dis 2020; 39(12): 2257-67.
[http://dx.doi.org/10.1007/s10096-020-03963-z] [PMID: 32601893]
[3]
Tarahomjoo S. Recent approaches in vaccine development against <b><i>streptococcus pneumoniae</i></b>. Microb Physiol 2014; 24(4): 215-27.
[http://dx.doi.org/10.1159/000365052] [PMID: 25196525]
[4]
Geno KA, Gilbert GL, Song JY, et al. Pneumococcal capsules and their types: Past, present, and future. Clin Microbiol Rev 2015; 28(3): 871-99.
[http://dx.doi.org/10.1128/CMR.00024-15] [PMID: 26085553]
[5]
Hocknell RE, Cleary DW, Srifeungfung S, Clarke SC. Serotype distribution of disease-causing Streptococcus pneumoniae in Thailand: A systematic review. Vaccine 2019; 37(24): 3159-66.
[http://dx.doi.org/10.1016/j.vaccine.2019.04.085] [PMID: 31060951]
[6]
Mohammadzadeh M, Pourakbari B, Mahmoudi S, Keshtkar A, Habibi-Anbouhi M, Mamishi S. Efficacy of whole-cell pneumococcal vaccine in mice: A systematic review and meta-analysis. Microb Pathog 2018; 122: 122-9.
[http://dx.doi.org/10.1016/j.micpath.2018.06.026] [PMID: 29908308]
[7]
Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS One 2017; 12(5): e0177113.
[http://dx.doi.org/10.1371/journal.pone.0177113] [PMID: 28486544]
[8]
Lalitha MK, Thomas K, Kumar RS, Steinhoff MC. Serotyping of Streptococcus pneumoniae by coagglutination with 12 pooled antisera. J Clin Microbiol 1999; 37(1): 263-5.
[http://dx.doi.org/10.1128/JCM.37.1.263-265.1999] [PMID: 9854110]
[9]
Ochoa TJ, Rupa R, Guerra H, et al. Penicillin resistance and serotypes/serogroups of Streptococcus pneumoniae in nasopharyngeal carrier children younger than 2 years in Lima, Peru. Diagn Microbiol Infect Dis 2005; 52(1): 59-64.
[http://dx.doi.org/10.1016/j.diagmicrobio.2004.12.014] [PMID: 15878444]
[10]
Lister AJJ, Le CF, Cheah ESG, Desa MNM, Cleary DW, Clarke SC. Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: A meta-analysis. Pneumonia 2021; 13(1): 9.
[http://dx.doi.org/10.1186/s41479-021-00086-7] [PMID: 34030731]
[11]
Essink B, Sabharwal C, Cannon K, et al. Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults aged ≥18 years. Clin Infect Dis 2022; 75(3): 390-8.
[http://dx.doi.org/10.1093/cid/ciab990] [PMID: 34940806]
[12]
Ishiwada N. Current situation and need for prevention of invasive pneumococcal disease and pneumococcal pneumonia in 6- to 64-year-olds in Japan. J Infect Chemother 2021; 27(1): 7-18.
[http://dx.doi.org/10.1016/j.jiac.2020.09.016] [PMID: 33011068]
[13]
Habibian S, Mehrabi-Tavana A, Ahmadi Z, et al. Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran. Iran Red Crescent Med J 2013; 15(10): e8053.
[http://dx.doi.org/10.5812/ircmj.8053] [PMID: 24693373]
[14]
Ezoji K, Yaghoubi M, Nojomi M, et al. Cost-effectiveness of introducing the pneumococcal conjugate vaccine for children under 5 years in the Islamic Republic of Iran. East Mediterr Health J 2019; 25(10): 686-97.
[http://dx.doi.org/10.26719/emhj.19.039] [PMID: 31774134]
[15]
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021; 372(71): n71.
[http://dx.doi.org/10.1136/bmj.n71] [PMID: 33782057]
[16]
Joanna Briggs Institute reviewers’ manual. 2017 edition. Australia: The Joanna Briggs Institute 2017.
[17]
Esteghamati A, Nazari-Alam A, Badamchi A, et al. Molecular characterization of streptococcus pneumoniae from patients diagnosed with pneumonia: Recommendation for vaccination program. Med J Islam Repub Iran 2022; 36: 150.
[http://dx.doi.org/10.47176/mjiri.36.150] [PMID: 36620470]
[18]
Tabatabaei SR, Shamshiri A, Azimi L, et al. Co-infection with dual Streptococcus pneumoniae serotypes as a cause of pediatric bacterial meningitis in Iran: A multi-center cross-sectional study. BMC Infect Dis 2022; 22(1): 625.
[http://dx.doi.org/10.1186/s12879-022-07606-w] [PMID: 35850636]
[19]
Abdoli S, Safamanesh S, Khosrojerdi M, Azimian A. Molecular detection and serotyping of streptococcus pneumoniae in children with suspected meningitis in northeast Iran. Iran J Med Sci 2020; 45(2): 125-33.
[http://dx.doi.org/10.30476/IJMS.2019.45423] [PMID: 32210489]
[20]
Habibi Ghahfarokhi S, Mosadegh M, Ahmadi A, et al. Serotype distribution and antibiotic susceptibility of streptococcus pneumoniae isolates in Tehran, Iran: A surveillance study. Infect Drug Resist 2020; 13: 333-40.
[http://dx.doi.org/10.2147/IDR.S234295] [PMID: 32099424]
[21]
Azarsa M, Ohadian Moghadam S, Rahbar M, Baseri Z, Pourmand MR. Molecular serotyping and genotyping of penicillin non-susceptible pneumococci: the introduction of new sequence types, Tehran, Iran. New Microbes New Infect 2019; 32: 100597.
[http://dx.doi.org/10.1016/j.nmni.2019.100597] [PMID: 31641513]
[22]
Pormohammad A, Lashkarbolouki S, Azimi T, et al. Clinical characteristics and molecular epidemiology of children with meningitis in Tehran, Iran: a prospective study. New Microbes New Infect 2019; 32: 100594.
[http://dx.doi.org/10.1016/j.nmni.2019.100594] [PMID: 31641511]
[23]
Talebi M, Sadeghi J, Ahmadi A, Lohrasbi V, Owlia P, Pourshafie MR. High rate of serotype switching and genetic variations indicates widespread recombination between clinical and commensal penicillin-nonsusceptible Streptococcus pneumoniae in Tehran. Microb Drug Resist 2019; 25(6): 865-73.
[http://dx.doi.org/10.1089/mdr.2018.0336] [PMID: 30785836]
[24]
Ahmadi A, Yaghoubi S, Irajian G. Molecular analysis of PBP1A in streptococcus pneumoniae isolated from clinical and normal flora samples in Tehran, Iran: A multicenter study. Microb Drug Resist 2019; 25(1): 39-46.
[http://dx.doi.org/10.1089/mdr.2017.0326] [PMID: 30070961]
[25]
Houri H, Tabatabaei SR, Saee Y, Fallah F, Rahbar M, Karimi A. Distribution of capsular types and drug resistance patterns of invasive pediatric Streptococcus pneumoniae isolates in Teheran, Iran. Int J Infect Dis 2017; 57: 21-6.
[http://dx.doi.org/10.1016/j.ijid.2017.01.020] [PMID: 28131730]
[26]
Shokri Moghadam M, Talebi M, Masjedian F, Irajian G, Pourshafie MR. Streptococcus pneumoniae serotyping by a single polymerase chain reaction–based multiplex assay. Infect Dis Clin Pract 2018; 26(2): 75-9.
[http://dx.doi.org/10.1097/IPC.0000000000000554]
[27]
Talebi M, Azadegan A, Sadeghi J, et al. Determination of characteristics of erythromycin resistant streptococcus pneumoniae with preferred PCV usage in Iran. PLoS One 2016; 11(12): e0167803.
[http://dx.doi.org/10.1371/journal.pone.0167803] [PMID: 28033345]
[28]
Attarpour-Yazdi MM, Ghamarian A, Mousaviehzadeh M, Davoudi N. Identification of the serotypes of bacterial meningitis agents; implication for vaccine usage. Iran J Microbiol 2014; 6(4): 211-8.
[PMID: 25802702]
[29]
Khoshdel A, Rastabi RI, Doosti A, Askari S, Hafizi M. Prevalence of heptavalent vaccine- related pneumococcal serotypes in nasopharyngeal carrier in children under five years old in shahrekord, Iran by multiplex-PCR during 2010- 2011. J Clin Diagn Res 2014; 8(11): PC01-4.
[http://dx.doi.org/10.7860/JCDR/2014/8970.5104] [PMID: 25584276]
[30]
Mirzaei GH, Moniri R, Moosavi SG, Rezaei M, Yasini M, Valipour M. Serotyping, antibiotic susceptibility and related risk factors aspects of nasopharyngeal carriage of streptococcus pneumoniae in healthy school students. Iran J Public Health 2014; 43(9): 1284-90.
[PMID: 26175983]
[31]
Mousavi SF, Nobari S, Rahmati Ghezelgeh F, et al. Serotyping of Streptococcus pneumoniae isolated from Tehran by Multiplex PCR: Are serotypes of clinical and carrier isolates identical? Iran J Microbiol 2013; 5(3): 220-6.
[PMID: 24475327]
[32]
Bokaeian M, Khazaei HA, Javadimehr M. Nasopharyngeal carriage, antibiotic resistance and serotype distribution of streptococcus pneumoniae among healthy adolescents in zahedan. Iran Red Crescent Med J 2011; 13(5): 328-33.
[33]
Habib M, Porter BD, Satzke C. Capsular serotyping of Streptococcus pneumoniae using the Quellung reaction. J Vis Exp 2014; 84(84): e51208.
[http://dx.doi.org/10.3791/51208] [PMID: 24637727]
[34]
Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 2006; 44(1): 124-31.
[http://dx.doi.org/10.1128/JCM.44.1.124-131.2006] [PMID: 16390959]
[35]
Fu J, Yi R, Jiang Y, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: A meta-analysis. BMC Pediatr 2019; 19(1): 424.
[http://dx.doi.org/10.1186/s12887-019-1722-1] [PMID: 31711442]
[36]
Men W, Dong Q, Shi W, Yao K. Serotype distribution and antimicrobial resistance patterns of invasive pneumococcal disease isolates from children in mainland China—a systematic review. Braz J Microbiol 2020; 51(2): 665-72.
[http://dx.doi.org/10.1007/s42770-019-00198-9] [PMID: 31797324]
[37]
Daningrat WOD, Amalia H, Ayu IM, Satzke C, Safari D. Carriage of Streptococcus pneumoniae in children under five years of age prior to pneumococcal vaccine introduction in Southeast Asia: A systematic review and meta-analysis (2001–2019). J Microbiol Immunol Infect 2022; 55(1): 6-17.
[http://dx.doi.org/10.1016/j.jmii.2021.08.002] [PMID: 34511388]
[38]
Singh J, Sundaresan S, Manoharan A, Shet A. Serotype distribution and antimicrobial susceptibility pattern in children ≤ 5 years with invasive pneumococcal disease in India – A systematic review. Vaccine 2017; 35(35) (35 Pt B): 4501-9.
[http://dx.doi.org/10.1016/j.vaccine.2017.06.079] [PMID: 28711387]
[39]
Hascelik G, Soyletir G, Gulay Z, et al. Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018. Ann Med 2023; 55(1): 266-75.
[http://dx.doi.org/10.1080/07853890.2022.2160877] [PMID: 36579976]
[40]
Ktari S, Ben Ayed N, Ben Rbeh I, et al. Antibiotic resistance pattern, capsular types, and molecular characterization of invasive isolates of Streptococcus pneumoniae in the south of Tunisia from 2012 to 2018. BMC Microbiol 2023; 23(1): 36.
[http://dx.doi.org/10.1186/s12866-023-02784-2] [PMID: 36739390]
[41]
Kim SH, Song JH, Chung DR, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: An Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012; 56(3): 1418-26.
[http://dx.doi.org/10.1128/AAC.05658-11] [PMID: 22232285]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy